The SARS-CoV-19 pandemic overwhelmed multiple healthcare systems across the world.
Patients with underlying medical conditions such as obesity or diabetes were particularly …

Abstract Adults with Diabetes Mellitus (DM) have increased risk of severe clinical
presentation during COVID-19 infection, while children and adolescents with type 1 diabetes …

Abstract Background Omicron variant (B. 1.1. 529) is a dominant variant worldwide.
However, the risk factors for Omicron variant clearance are yet unknown. The present study …

Background Patients with diabetes and obesity are populations at high-risk for severe
COVID-19 outcomes and have shown blunted immune responses when administered …

Introduction Diabetes mellitus worsens the prognosis of SARS‐CoV‐2 infection, and
vaccination has been the major tool for reducing the risk of hospitalisation, and mortality …

Objective: To assess whether the immunogenicity of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) vaccines or breakthrough infection rates differ between …

Aims Diabetes mellitus (DM), one of the most common chronic diseases in China, is a risk
factor for SARS-COV-2 infection and poor prognosis of COVID-19. The COVID-19 vaccine is …

Background Studies combining data from digital surveys and electronic health records
(EHR) can be used to conduct comprehensive assessments on COVID-19 vaccine safety …

While the immunogenicity of SARS-CoV-2 vaccines has been well described in adults,
pediatric populations have been less studied. In particular, children with type 1 diabetes are …

Introduction The mRNA-based BNT162b2 (Pfizer-BioNTech) vaccine has been shown to
elicit robust systemic immune response and confer substantial protection against the severe …